COMPARISON OF DOXORUBICIN-INDUCED DNA DAMAGE IN DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT P388 MURINE LEUKEMIA-CELLS

被引：57

作者：

CAPRANICO, G ^{[1
]}

DASDIA, T ^{[1
]}

ZUNINO, F ^{[1
]}

机构：

[1] IST NAZL STUDIO & CURA TUMORI,DIV EXPTL ONCOL B,I-20133 MILAN,ITALY

来源：

关键词：

D O I：

10.1002/ijc.2910370210

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：227 / 231

页数：5

共 26 条

[1] CELLULAR PHARMACODYNAMICS OF SEVERAL ANTHRACYCLINE ANTIBIOTICS
BACHUR, NR
STEELE, M
MERIWETHER, WD
HILDEBRAND, RC
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (05) : 651 - 654
[2] BIEDLER JL, 1983, CANCER TREAT REP, V67, P859
[3] Chabner B. A., 1982, CANCER PRINCIPLES PR, P156
[4] DEVITA VT, 1983, CANCER, V51, P1209, DOI 10.1002/1097-0142(19830401)51:7<1209::AID-CNCR2820510707>3.0.CO
[5] 2-J
[6] GOLDIE JH, 1984, CANCER RES, V44, P3643
[7] UPTAKE AND RETENTION OF ADRIAMYCIN AND DAUNORUBICIN BY SENSITIVE AND ANTHRACYCLINE-RESISTANT SUBLINES OF P388-LEUKEMIA
INABA, M
JOHNSON, RK
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (17) : 2123 - 2130
[8] JOHNSON RK, 1978, CANCER TREAT REP, V62, P1535
[9] CELL-SURFACE P-GLYCOPROTEIN ASSOCIATED WITH MULTIDRUG RESISTANCE IN MAMMALIAN-CELL LINES
KARTNER, N
RIORDAN, JR
LING, V
[J]. SCIENCE, 1983, 221 (4617) : 1285 - 1288
[10] TUMOR-CELL RESISTANCE TO ANTHRACYCLINES - A REVIEW
KAYE, S
MERRY, S
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) : 96 - 103